NCT01133587

Brief Summary

To meet the requirement for increased patient involvement, several Community Mental Health Centres (CMHC) have initiated a service called "patient-guided admissions". The investigators will compare a group with "patient guided admission/self-referral to inpatient beds" with a group having treatment as usual. It is expected that patients in the intervention group will experience more increased feeling of coping (patient activation) after 4 months and 12 months as a result of participating in "patient-guided admissions" than patients getting treatment as usual. In addition the total number of inpatient days either in the CMHC, psychiatric hospital or community rehabilitation centre is expected to be clearly lower in the intervention group than in the 'treatment-as-usual' group during one year after intake. Also the number of involuntary admissions either as inpatient or outpatient will be significant lower in the intervention group than the 'treatment-as-usual' group.The number of admissions in CMHC and psychiatric hospital, as well as the number of outpatient consultations in primary care, CMHC and psychiatric hospitals, will be lower in the intervention group than in the 'treatment-as-usual' group. Patients in the intervention group will experience improved mental health, increased feeling of coping (patient activation) and increased experience of recovery after 4 months and 12 months as a result of participating in "patient-guided admissions".

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
53

participants targeted

Target at P25-P50 for not_applicable schizophrenia

Timeline
Completed

Started May 2010

Typical duration for not_applicable schizophrenia

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2010

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

May 19, 2010

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 31, 2010

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
Last Updated

April 4, 2017

Status Verified

March 1, 2017

Enrollment Period

3.6 years

First QC Date

May 19, 2010

Last Update Submit

March 31, 2017

Conditions

Keywords

Schizophreniabipolar disorderLong term carepatient admission

Outcome Measures

Primary Outcomes (2)

  • Patient activation/coping

    Patient Activation Measure (PAM 13)

    4 months

  • Patient activation/coping

    Patient Activation Measure (PAM 13)

    12 months

Secondary Outcomes (6)

  • Number of admissions

    12 months

  • Total number of inpatient days

    12 months

  • Number of outpatient consultations

    12 months

  • Number of involuntary admissions

    12 months

  • Symptoms/functioning and recovery

    4 months

  • +1 more secondary outcomes

Study Arms (2)

admissions contract

EXPERIMENTAL

contract regarding "patient-guided admissions"

Behavioral: admissions contract

wait list control

ACTIVE COMPARATOR

1 year on waiting list

Other: wait list control

Interventions

Patient-guided admissions contract regarding "patient-guided admissions" starting a year after.

wait list control

contract regarding "patient-guided admissions" starting immediately

admissions contract

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • schizophrenia or bipolar disorder
  • long term care
  • established relationship with the ward

You may not qualify if:

  • extensive substance use problems
  • self-destructive behavior
  • not able to consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St.Olavs hospital, Psykisk helsevern, Nidaros DPS

Trondheim, 7440, Norway

Location

Related Publications (3)

  • Moljord IE, Helland-Hansen KA, Salvesen O, Olso TM, Gudde CB, Rise MB, Steinsbekk A, Eriksen L. Short time effect of a self-referral to inpatient treatment for patients with severe mental disorders: a randomized controlled trial. BMC Health Serv Res. 2016 Sep 22;16(1):513. doi: 10.1186/s12913-016-1712-z.

  • Moljord IEO, Lara-Cabrera ML, Salvesen O, Rise MB, Bjorgen D, Antonsen DO, Olso TM, Evensen GH, Gudde CB, Linaker OM, Steinsbekk A, Eriksen L. Twelve months effect of self-referral to inpatient treatment on patient activation, recovery, symptoms and functioning: A randomized controlled study. Patient Educ Couns. 2017 Jun;100(6):1144-1152. doi: 10.1016/j.pec.2017.01.008. Epub 2017 Jan 11.

  • Sigrunarson V, Moljord IE, Steinsbekk A, Eriksen L, Morken G. A randomized controlled trial comparing self-referral to inpatient treatment and treatment as usual in patients with severe mental disorders. Nord J Psychiatry. 2017 Feb;71(2):120-125. doi: 10.1080/08039488.2016.1240231. Epub 2016 Oct 14.

MeSH Terms

Conditions

SchizophreniaBipolar Disorder

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental DisordersBipolar and Related DisordersMood Disorders

Study Officials

  • Lasse Eriksen, PhD

    St. Olavs Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 19, 2010

First Posted

May 31, 2010

Study Start

May 1, 2010

Primary Completion

December 1, 2013

Study Completion

December 1, 2013

Last Updated

April 4, 2017

Record last verified: 2017-03

Locations